Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study

BACKGROUND: The aim of this study was to prospectively analyse, for the first time worldwide by in vivo clinical confocal microscopy (CCM), corneal side effects secondary to the use of epidermal growth factor receptor (EGFR) inhibitor depatuxizumab mafodotin (ABT-414) in a cohort of patients affecte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Med Oncol
Main Authors: Parrozzani, Raffaele, Lombardi, Giuseppe, Midena, Edoardo, Leonardi, Francesca, Londei, Davide, Padovan, Marta, Caccese, Mario, Marchione, Giulia, Bini, Silvia, Zagonel, Vittorina, Frizziero, Luisa
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7278095/
https://ncbi.nlm.nih.gov/pubmed/32550861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920907543
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados